Skip to main content
. 2017 Jul 5;19(12):1661–1672. doi: 10.1093/neuonc/nox122

Fig. 2.

Fig. 2

Overview of the treatment regimen for the treatment of patients with intracranial malignant NGGCTs on the SIOP-CNS-GCT-96 trial protocol.